GO:0050354 triokinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050354 triokinase activity catalyzes the ATP-dependent phosphorylation of D-glyceraldehyde to D-glyceraldehyde 3-phosphate, a reaction that feeds triose phosphates into glycolysis and gluconeogenesis.
• In humans, triokinase activity is carried by TKFC (triokinase/FMN cyclase), a bifunctional homodimeric enzyme that also produces cyclic FMN.
• The TKFC Ala185Thr variant, previously described as null for fructose metabolism, retains full triokinase activity, showing that genotype-phenotype interpretation requires direct enzymatic assays.
• Alternative splicing of the last TKFC intron yields transcripts that differ across human tissues and can encode a protein devoid of triokinase and FMN cyclase activity.
• Triokinase activity supports dihydroxyacetone phosphate (DHAP) production, and DHAP signals glucose availability to mTORC1, linking triose metabolism to nutrient sensing.
• Triokinase/FMN cyclase is a target of curcumin in metabolic dysfunction-associated steatotic liver disease, where it regulates glycerol-3-phosphate acyltransferase 3 expression.
Description
Triokinase activity (GO:0050354) is a molecular function defined by the reaction D-glyceraldehyde + ATP = D-glyceraldehyde 3-phosphate + ADP + 2 H+. This reaction places triokinase at the intersection of triose metabolism and phosphate transfer, because it converts the three-carbon aldehyde D-glyceraldehyde into the phosphorylated triose D-glyceraldehyde 3-phosphate, which can then enter glycolytic/gluconeogenic routes. The function was demonstrated in human erythrocytes, where dihydroxyacetone metabolism depends on triokinase activity and the enzyme was biochemically characterized. In pancreatic islets, glyceraldehyde can enter metabolism through both triokinase and glyceraldehyde phosphate dehydrogenase reactions, indicating that triokinase contributes to islet triose handling. In humans, triokinase activity is not carried by a standalone kinase but by TKFC, a bifunctional homodimeric enzyme that also has FMN cyclase activity. The TKFC protein architecture and domain movements have been studied to understand how one polypeptide supports two chemically distinct reactions. Naturally occurring TKFC variants and splice isoforms further complicate annotation: the Ala185Thr variant, reported as null for fructose metabolism, is fully active as triokinase, and alternative splicing of the last TKFC intron produces transcripts that are differentially expressed in human tissues and can encode a protein devoid of triokinase and FMN cyclase activity. For researchers, GO:0050354 matters because triokinase activity connects simple trioses to central carbon metabolism and to signaling. Dihydroxyacetone phosphate, the phosphorylated product of the triokinase pathway, signals glucose availability to mTORC1. In addition, triokinase/FMN cyclase has been identified as a target of curcumin in metabolic dysfunction-associated steatotic liver disease, where it regulates glycerol-3-phosphate acyltransferase 3 expression. These findings make triokinase activity relevant to metabolic disease, nutrient sensing, and enzyme-function annotation.
triokinase activity At A Glance
| GO ID | GO:0050354 |
|---|---|
| GO term | triokinase activity |
| Ontology | molecular_function |
| Synonym | ATP:D-glyceraldehyde 3-phosphotransferase activity; D-triokinase activity; triose kinase activity; trio triose kinase (phosphorylating) |
| Major function | Catalysis of D-glyceraldehyde + ATP = D-glyceraldehyde 3-phosphate + ADP + 2 H+ |
| Human enzyme | TKFC (triokinase/FMN cyclase), a bifunctional homodimeric enzyme |
| Pathway context | Triose phosphate metabolism, glycolysis/gluconeogenesis, fructose metabolism |
| Disease relevance | Metabolic dysfunction-associated steatotic liver disease and nutrient signaling |
What Is GO:0050354?
Triokinase activity is the catalytic activity that transfers a phosphate group from ATP to D-glyceraldehyde, producing D-glyceraldehyde 3-phosphate, ADP, and two protons. It is classified as a molecular function (GO:0050354) and is also known as ATP:D-glyceraldehyde 3-phosphotransferase activity, D-triokinase activity, triose kinase activity, and trio triose kinase (phosphorylating). The reaction enables cells to phosphorylate a three-carbon aldehyde so that it can be metabolized through triose phosphate pathways.
Why Is triokinase activity Important in Cell Biology?
Triokinase activity is important because it provides a route for D-glyceraldehyde and related trioses to enter phosphorylated metabolic pools. In human erythrocytes, dihydroxyacetone metabolism requires triokinase activity, establishing the enzyme as a physiologically relevant triose kinase. In pancreatic islets, glyceraldehyde can be metabolized through both triokinase and glyceraldehyde phosphate dehydrogenase reactions, so triokinase contributes to islet triose flux. The product of the triokinase reaction, D-glyceraldehyde 3-phosphate, lies on the glycolytic/gluconeogenic map, and the related metabolite dihydroxyacetone phosphate signals glucose availability to mTORC1. In humans, triokinase activity is embedded in the bifunctional TKFC enzyme, whose splice isoforms and variants can alter measured activity. Finally, triokinase/FMN cyclase is a curcumin target in metabolic dysfunction-associated steatotic liver disease, where it regulates glycerol-3-phosphate acyltransferase 3 expression.
• Provides an ATP-dependent route from D-glyceraldehyde to D-glyceraldehyde 3-phosphate, feeding triose phosphate metabolism.
• Explains how dihydroxyacetone is metabolized in human erythrocytes.
• Contributes to glyceraldehyde metabolism in pancreatic islets alongside glyceraldehyde phosphate dehydrogenase.
• Links triose metabolism to mTORC1 signaling through dihydroxyacetone phosphate.
• Is carried by the bifunctional TKFC enzyme, connecting triokinase activity to FMN cyclase activity.
• Requires careful interpretation of TKFC variants such as Ala185Thr, which is fully active as triokinase despite being reported as null for fructose metabolism.
• Is affected by alternative splicing of TKFC transcripts that can encode a protein devoid of triokinase activity.
• Is relevant to metabolic dysfunction-associated steatotic liver disease through curcumin targeting of triokinase/FMN cyclase.
• Supports biochemical annotation of triose kinase reactions in metabolic models.
• Provides a functional readout for CRISPR models targeting TKFC and related metabolic genes.
Molecular Mechanism of triokinase activity
Substrate recognition and phosphoryl transfer
In simple terms: Triokinase takes a phosphate from ATP and puts it onto D-glyceraldehyde.
The defining reaction of GO:0050354 is D-glyceraldehyde + ATP = D-glyceraldehyde 3-phosphate + ADP + 2 H+. This reaction was demonstrated and characterized in human erythrocytes, where triokinase activity accounts for dihydroxyacetone metabolism. The enzyme therefore recognizes a three-carbon aldehyde substrate and uses ATP as the phosphate donor, producing a phosphorylated triose.
Bifunctional TKFC enzyme architecture
In simple terms: The human enzyme that does this reaction is a two-in-one protein called TKFC.
In humans, triokinase activity is contributed by TKFC, a bifunctional homodimeric triokinase/FMN cyclase. Studies of the human enzyme have examined the contribution of protein domains to the two activities and used molecular dynamics to simulate domain movements, providing a structural basis for how one enzyme can catalyze both triokinase and FMN cyclase reactions.
Isoforms, splice variants, and activity
In simple terms: Different versions of the TKFC message can change whether triokinase activity is present.
Alternative splicing of the last TKFC intron yields transcripts that are differentially expressed in human tissues and code in vitro for a protein devoid of triokinase and FMN cyclase activity. This means that transcript-level annotation alone may not predict triokinase activity, and isoform-specific assays are needed.
Variant effects on triokinase activity
In simple terms: A known TKFC variant does not actually lose triokinase activity.
The TKFC Ala185Thr variant, reported as null for fructose metabolism, is fully active as triokinase. This finding shows that triokinase activity must be measured directly rather than inferred from fructose-metabolism phenotypes or variant labels.
Metabolic and signaling context
In simple terms: The product of triokinase helps cells sense glucose and make lipids.
Dihydroxyacetone phosphate signals glucose availability to mTORC1, connecting triose phosphate metabolism to nutrient sensing. In pancreatic islets, glyceraldehyde can enter metabolism via both triokinase and glyceraldehyde phosphate dehydrogenase reactions, indicating that triokinase participates in islet triose handling. Triokinase/FMN cyclase is also a curcumin target in metabolic dysfunction-associated steatotic liver disease, where it regulates glycerol-3-phosphate acyltransferase 3 expression.
Key Genes Involved in GO:0050354 triokinase activity
The genes and proteins below are directly implicated in triokinase activity (GO:0050354), its regulation, or the metabolic pathways that use its product.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TKFC | Bifunctional triokinase/FMN cyclase carrying triokinase activity in humans | Core enzyme for GO:0050354; domain and isoform studies |
| TKFC (Ala185Thr variant) | Variant reported as null for fructose metabolism but fully active as triokinase | Benchmark for genotype-enzyme activity discordance |
| TKFC splice isoforms | Alternatively spliced transcripts differentially expressed in human tissues; some encode protein devoid of triokinase activity | Isoform-specific functional annotation |
| GAPDH | Glyceraldehyde phosphate dehydrogenase, alternative route for glyceraldehyde metabolism in islets | Comparative flux studies with triokinase |
| KHK | Ketohexokinase, fructose metabolism enzyme compared with triokinase pathway | Dissecting fructose versus triose metabolism |
| GPAT3 | Glycerol-3-phosphate acyltransferase 3, regulated downstream of triokinase/FMN cyclase in MASLD | Lipid synthesis readout for triokinase targeting |
| mTORC1 pathway components | Signaling axis responsive to dihydroxyacetone phosphate | Nutrient-sensing studies linked to triose metabolism |
| Erythrocyte metabolic enzymes | Context for the original characterization of human triokinase activity | Biochemical assay development |
| Pancreatic islet metabolic enzymes | Context for glyceraldehyde entry via triokinase | Islet metabolism research |
| FMN cyclase (TKFC domain) | Second activity of the bifunctional TKFC enzyme | Domain-function dissection |
| Dihydroxyacetone phosphate metabolic enzymes | Produce or consume DHAP, the triokinase pathway product | Metabolic flux and signaling studies |
| Fructose metabolism enzymes | Pathway context for TKFC variant interpretation | Variant reclassification |
| Curcumin-targeted proteins | Chemical proteomics context for triokinase/FMN cyclase | Drug-target studies in MASLD |
| Triose phosphate isomerase pathway components | Interconversion of triose phosphates downstream of triokinase | Metabolic labeling studies |
| Glycolytic enzymes | Use D-glyceraldehyde 3-phosphate produced by triokinase | Central carbon metabolism research |
| Gluconeogenic enzymes | Can use triose phosphates derived from triokinase activity | Gluconeogenesis research |
How Is triokinase activity Regulated?
Triokinase activity is regulated at multiple levels. At the transcript level, alternative splicing of the last TKFC intron yields transcripts that are differentially expressed in human tissues and can encode a protein devoid of triokinase and FMN cyclase activity, providing a splicing-dependent control point. At the protein level, TKFC is a bifunctional homodimer whose domains contribute differently to triokinase and FMN cyclase activities, and molecular dynamics simulations have been used to study domain movements relevant to catalysis. At the variant level, the TKFC Ala185Thr change does not abolish triokinase activity even though it was reported as null for fructose metabolism, indicating that regulation cannot be inferred from fructose pathway phenotypes alone. Metabolically, triokinase activity is embedded in triose phosphate metabolism, and the related metabolite dihydroxyacetone phosphate signals glucose availability to mTORC1, linking triokinase pathway output to nutrient-sensing regulation. In disease contexts, triokinase/FMN cyclase is targeted by curcumin in metabolic dysfunction-associated steatotic liver disease and regulates glycerol-3-phosphate acyltransferase 3 expression, adding a pharmacological and transcriptional layer of regulation.
triokinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TKFC | Metabolic dysfunction-associated steatotic liver disease; curcumin target regulating GPAT3 | Hepatocyte cell models with TKFC knockout or overexpression |
| TKFC (Ala185Thr) | Variant reported as null for fructose metabolism but fully active as triokinase | Isogenic point-mutation cell lines |
| TKFC splice isoforms | Tissue-specific transcripts encoding protein devoid of triokinase activity | Isoform-specific knockout or splice-site editing |
| KHK | Fructose metabolism divergence between knockdown and kinase inhibition | KHK knockdown and point-mutation models |
| DHAP/mTORC1 axis | Glucose availability signaling to mTORC1 | Metabolite-sensing reporter cell lines |
Metabolic dysfunction-associated steatotic liver disease (MASLD)
Triokinase/FMN cyclase is a target of curcumin in metabolic dysfunction-associated steatotic liver disease, where curcumin ameliorates metabolic dysfunction by regulating glycerol-3-phosphate acyltransferase 3 expression. This links triokinase activity to hepatic lipid metabolism and suggests that the enzyme can be modulated pharmacologically.
Fructose metabolism and variant interpretation
The TKFC Ala185Thr variant was reported as null for fructose metabolism but is fully active as triokinase. This has direct implications for how variants in fructose-metabolism genes are classified and shows that triokinase activity can be retained even when fructose pathway phenotypes are abnormal. Knockdown of ketohexokinase versus inhibition of its kinase activity exerts divergent effects on fructose metabolism, highlighting the need to separate enzyme abundance from catalytic activity when studying related pathways.
Nutrient sensing and mTORC1 signaling
Dihydroxyacetone phosphate signals glucose availability to mTORC1. Because triokinase activity contributes to triose phosphate pools, changes in triokinase function could influence DHAP levels and therefore nutrient-sensing outputs. This provides a mechanistic bridge between GO:0050354 and growth-signaling pathways.
Isoform and tissue-specific expression
Alternative splicing of the last TKFC intron yields transcripts that are differentially expressed in human tissues and can encode a protein devoid of triokinase and FMN cyclase activity. Tissue-specific isoform expression may therefore contribute to differences in triokinase activity across organs and should be considered in disease studies.
From triokinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TKFC abolish cellular triokinase activity? | TKFC knockout cell line |
| Does the Ala185Thr variant retain triokinase activity? | Point-mutation knock-in of TKFC Ala185Thr |
| Which TKFC isoform carries triokinase activity? | Isoform-specific knockout or splice-site editing |
| Can triokinase activity be monitored in living cells? | Tagged knock-in of TKFC with a fluorescent or affinity tag |
| Does TKFC overexpression alter lipid metabolism? | TKFC overexpression in hepatocyte models |
| How does triokinase pathway output affect mTORC1? | DHAP-responsive mTORC1 reporter cells |
How to Study the triokinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Triokinase enzymatic assay | ATP-dependent conversion of D-glyceraldehyde to D-glyceraldehyde 3-phosphate | Validation of TKFC variants and knockouts |
| RNA-seq / isoform analysis | TKFC transcript and splice isoform expression | Tissue-specific isoform annotation |
| Chemical proteomics | Drug-enzyme interactions, e.g. curcumin with triokinase/FMN cyclase | Target identification in MASLD models |
| Transcriptomics | Downstream gene expression changes such as GPAT3 | Pathway response to triokinase modulation |
| Metabolite profiling | DHAP and triose phosphate levels | Nutrient-sensing studies |
| mTORC1 reporter assays | Signaling response to glucose availability via DHAP | Linking triose metabolism to growth signaling |
| Islet metabolic flux assays | Glyceraldehyde entry via triokinase versus GAPDH | Pancreatic islet metabolism research |
| Domain/molecular dynamics analysis | TKFC domain contributions and movements | Structure-function studies of bifunctional enzyme |
Enzymatic assays for triokinase activity
Triokinase activity can be measured by following the ATP-dependent conversion of D-glyceraldehyde to D-glyceraldehyde 3-phosphate, as originally demonstrated and characterized in human erythrocytes. Such assays are essential for distinguishing true activity changes from expression changes, especially for TKFC variants such as Ala185Thr that retain triokinase activity.
Transcript and isoform analysis
Because alternative splicing of the last TKFC intron yields transcripts that are differentially expressed in human tissues and can encode a protein devoid of triokinase and FMN cyclase activity, RNA-level methods are needed to resolve isoform expression. These methods complement enzymatic assays by revealing which TKFC transcripts are present.
Proteomics and chemical proteomics
Chemical proteomics and transcriptomics have been integrated to identify triokinase/FMN cyclase as a curcumin target in metabolic dysfunction-associated steatotic liver disease. Such approaches can reveal drug-enzyme interactions and downstream expression changes, including regulation of glycerol-3-phosphate acyltransferase 3.
Metabolic and signaling readouts
Dihydroxyacetone phosphate signals glucose availability to mTORC1, so metabolic and signaling readouts can be used to connect triokinase pathway activity to nutrient sensing. In pancreatic islets, glyceraldehyde entry via triokinase versus glyceraldehyde phosphate dehydrogenase can be assessed to understand pathway contribution.
How CRISPR Can Be Used to Study GO:0050354 triokinase activity
Knockout
CRISPR knockout of TKFC can be used to eliminate triokinase activity and test its contribution to triose phosphate metabolism, DHAP-dependent mTORC1 signaling, and lipid gene regulation. Knockout models are also useful for validating whether observed phenotypes depend on triokinase activity or on the FMN cyclase activity of the same bifunctional enzyme.
Point Mutation
Point-mutation knock-in of TKFC Ala185Thr allows direct testing of the variant that was reported as null for fructose metabolism but is fully active as triokinase. Such isogenic models help separate variant effects on triokinase activity from effects on other pathways.
Knock-in
Tagged knock-in of TKFC can be used to monitor protein localization, interactions, and abundance while preserving endogenous regulation. Knock-in of specific splice isoforms can also test which TKFC transcripts support triokinase activity, given that some isoforms encode a protein devoid of triokinase and FMN cyclase activity.
Overexpression
Overexpression of TKFC in hepatocyte or metabolic cell models can test whether increased triokinase activity alters glycerol-3-phosphate acyltransferase 3 expression and lipid metabolism, as suggested by curcumin-targeting studies in MASLD. Overexpression can also be combined with metabolite profiling to assess DHAP levels and mTORC1 signaling.
How EDITGENE Supports triokinase activity Research
Researchers studying triokinase activity-related genes often need to determine whether a candidate gene is causally involved in triose phosphate metabolism, nutrient sensing, or metabolic disease. EDITGENE provides CRISPR-based cell models and screening services that allow direct testing of TKFC and related genes at the level of knockout, point mutation, knock-in, and overexpression, with bioinformatics support for interpreting the resulting metabolic and transcriptomic data.
Contact EDITGENE today to design your custom CRISPR model for triokinase activity research.
Frequently Asked Questions About triokinase activity
What is triokinase activity?
Triokinase activity (GO:0050354) is the catalysis of D-glyceraldehyde + ATP = D-glyceraldehyde 3-phosphate + ADP + 2 H+, a reaction that phosphorylates a three-carbon aldehyde using ATP.
What gene encodes triokinase activity in humans?
In humans, triokinase activity is carried by TKFC, a bifunctional homodimeric triokinase/FMN cyclase enzyme.
What is the reaction catalyzed by triokinase?
The reaction is D-glyceraldehyde + ATP = D-glyceraldehyde 3-phosphate + ADP + 2 H+, as defined for GO:0050354.
Is triokinase activity the same as FMN cyclase activity?
No. They are two distinct activities of the bifunctional TKFC enzyme, and studies have examined how different protein domains contribute to each activity.
Does the TKFC Ala185Thr variant lose triokinase activity?
No. The TKFC Ala185Thr variant, reported as null for fructose metabolism, is fully active as triokinase.
How is triokinase activity measured?
Triokinase activity can be measured by following the ATP-dependent conversion of D-glyceraldehyde to D-glyceraldehyde 3-phosphate, as demonstrated in human erythrocytes.
Why is triokinase activity important for metabolism?
It feeds D-glyceraldehyde 3-phosphate into triose phosphate metabolism, and the related metabolite dihydroxyacetone phosphate signals glucose availability to mTORC1.
Is triokinase activity involved in liver disease?
Triokinase/FMN cyclase is a curcumin target in metabolic dysfunction-associated steatotic liver disease, where it regulates glycerol-3-phosphate acyltransferase 3 expression.
Can alternative splicing affect triokinase activity?
Yes. Alternative splicing of the last TKFC intron yields transcripts that are differentially expressed in human tissues and can encode a protein devoid of triokinase and FMN cyclase activity.
What experimental models are used to study triokinase activity?
Knockout, point-mutation, knock-in, and overexpression cell models targeting TKFC are used, together with enzymatic assays, transcriptomics, proteomics, and metabolic profiling.
Conclusion
Triokinase activity (GO:0050354) is a defined molecular function that phosphorylates D-glyceraldehyde to D-glyceraldehyde 3-phosphate using ATP. In humans, this activity is carried by the bifunctional TKFC enzyme, whose isoforms and variants can substantially affect measured activity. The pathway connects triose metabolism to nutrient sensing through dihydroxyacetone phosphate and mTORC1, and to metabolic disease through curcumin targeting of triokinase/FMN cyclase and regulation of glycerol-3-phosphate acyltransferase 3. Because triokinase activity can be retained in variants labeled as null for fructose metabolism, and because splice isoforms can encode inactive protein, direct functional models are essential. CRISPR-based knockout, point-mutation, knock-in, and overexpression cell models, combined with enzymatic, transcriptomic, proteomic, and metabolic readouts, provide a rigorous framework for studying triokinase activity in health and disease.
References
- 1. Orozco JM et al.. 2020. Dihydroxyacetone phosphate signals glucose availability to mTORC1.. Nat Metab 2(9):893-901 PMID: 32719541
- 2. Costas MJ et al.. 2024. Alternative Splicing of the Last TKFC Intron Yields Transcripts Differentially Expressed in Human Tissues That Code In Vitro for a Protein Devoid of Triokinase and FMN Cyclase Activity.. Biomolecules 14(10) PMID: 39456221
- 3. Park SH et al.. 2024. Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism.. JCI Insight 9(23) PMID: 39418102
- 4. Ribeiro JM et al.. 2022. The TKFC Ala185Thr variant, reported as 'null' for fructose metabolism, is fully active as triokinase.. FEBS Lett 596(11):1453-1457 PMID: 35114011
- 5. Beutler E et al.. 1973. Dihydroxyacetone metabolism by human erythrocytes: demonstration of triokinase activity and its characterization.. Blood 41(4):559-68 PMID: 4688871
- 6. Rodrigues JR et al.. 2014. Bifunctional homodimeric triokinase/FMN cyclase: contribution of protein domains to the activities of the human enzyme and molecular dynamics simulation of domain movements.. J Biol Chem 289(15):10620-10636 PMID: 24569995
- 7. Zhao C et al.. 2026. Curcumin ameliorates metabolic dysfunction-associated steatotic liver disease via targeting triokinase/FMN cyclase to regulate the expression of glycerol-3-phosphate acyltransferase 3: Integration of chemical proteomics and transcriptomics.. Acta Pharm Sin B 16(5):3026-3042 PMID: 42180525
- 8. MacDonald MJ. 1989. Does glyceraldehyde enter pancreatic islet metabolism via both the triokinase and the glyceraldehyde phosphate dehydrogenase reactions? A study of these enzymes in islets.. Arch Biochem Biophys 270(1):15-22 PMID: 2539042
